Articles with "dihydro pyrrolo" as a keyword



Photo from wikipedia

Synthesis and biological evaluation of N4 -hydrazone derivatives of 5,7-dihydro-6H-pyrrolo[2,3-d]pyrimidin-6-one as novel anticancer agents with antimetastatic adjunct efficacy.

Sign Up to like & get
recommendations!
Published in 2021 at "Archiv der Pharmazie"

DOI: 10.1002/ardp.202100213

Abstract: To obtain new anticancer agents with antimetastatic adjunct efficacy, a series of novel N4 -hydrazone derivatives of 5,7-dihydro-6H-pyrrolo[2,3-d]pyrimidin-6-one were designed and synthesized by an eight-step reaction, with appropriate yields. All the synthesized compounds were evaluated… read more here.

Keywords: pyrimidin one; pyrrolo pyrimidin; dihydro pyrrolo; adjunct efficacy ... See more keywords
Photo by louishansel from unsplash

Discovery of 5,7-Dihydro-6H-pyrrolo[2,3-d]pyrimidin-6-ones as Highly Selective CDK2 Inhibitors.

Sign Up to like & get
recommendations!
Published in 2022 at "ACS medicinal chemistry letters"

DOI: 10.1021/acsmedchemlett.2c00408

Abstract: A series of exceptionally selective CDK2 inhibitors are described. Starting from an HTS hit, we successfully scaffold hopped to a 5,7-dihydro-6H-pyrrolo[2,3-d]pyrimidin-6-one core structure, which imparted a promising initial selectivity within the CDK family. Extensive further… read more here.

Keywords: pyrrolo pyrimidin; selective cdk2; dihydro pyrrolo; cdk2 inhibitors ... See more keywords

Synthesis and Cyclooxygenase Inhibition of Sulfonamide-Substituted (Dihydro)Pyrrolo[3,2,1-hi]indoles and Their Potential Prodrugs

Sign Up to like & get
recommendations!
Published in 2019 at "Molecules"

DOI: 10.3390/molecules24203807

Abstract: Non-invasive imaging of cyclooxygenase-2 (COX-2) by radiolabeled ligands is attractive for the diagnosis of cancer, and novel highly affine leads with optimized pharmacokinetic profile are of great interest for future developments. Recent findings have shown… read more here.

Keywords: substituted dihydro; inhibition; pyrrolo indoles; dihydro pyrrolo ... See more keywords